Congenica Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 57

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $2.64M

  • Investors
  • 21

Congenica General Information

Description

Developer of a clinical genome interpretation platform designed to identify genetic diseases in patients. The company's platform processes genomic datasets to detect mutations by filtering clinically relevant variants and deep clinical phenotyping, enabling clinicians and researchers with personalized medicine approaches, and driving advancements in research and clinical care.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • BIC, Wellcome Genome Campus
  • Hinxton
  • Cambridge CB10 1DR
  • England, United Kingdom
+44 01223
Primary Industry
Decision/Risk Analysis
Corporate Office
  • BIC, Wellcome Genome Campus
  • Hinxton
  • Cambridge CB10 1DR
  • England, United Kingdom
+44 01223

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Congenica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Grant 01-May-2021 $2.64M Completed Generating Revenue
11. Later Stage VC (Series C) 09-Nov-2020 Completed Generating Revenue
10. Later Stage VC (Series B) 30-Apr-2019 Completed Generating Revenue
9. Grant 01-Sep-2018 Completed Generating Revenue
8. Later Stage VC 01-Mar-2017 Completed Generating Revenue
7. Secondary Transaction - Private 01-Jan-2016 Completed Generating Revenue
6. Grant 29-Sep-2015 Completed Generating Revenue
5. Early Stage VC (Series A) 01-Apr-2015 Completed Generating Revenue
4. Grant 11-Mar-2015 $4.59M $3.27M Completed Startup
3. Seed Round 05-Dec-2014 $2.45M $3.27M Completed Startup
To view Congenica’s complete valuation and funding history, request access »

Congenica Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
C Ordinary
B Ordinary
A Ordinary
B Ordinary
A Ordinary
A Ordinary 4,396,070 $0.001301 $0.65 $0.65 1x $0.65 7.66%
A Ordinary 2,553,500 $0.001301 $0.25 $0.25 1x $0.25 4.45%
To view Congenica’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Congenica Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a clinical genome interpretation platform designed to identify genetic diseases in patients. The company's
Decision/Risk Analysis
Cambridge, United Kingdom
57 As of 2024

Creve Coeur, MO
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Congenica Competitors (30)

One of Congenica’s 30 competitors is PierianDx, a Private Equity-Backed company based in Creve Coeur, MO.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PierianDx Private Equity-Backed Creve Coeur, MO
Superfluid DX Venture Capital-Backed South San Francisco, CA
Genalice Formerly PE-Backed Harderwijk, Netherlands
Rosalind (Decision/Risk Analysis) Venture Capital-Backed San Diego, CA
Fabric Genomics Formerly VC-backed Oakland, CA
You’re viewing 5 of 30 competitors. Get the full list »

Congenica Patents

Congenica Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4441742-A1 Next generation prenatal screening Pending 03-Dec-2021
GB-202117510-D0 Next generation prenatal screening Pending 03-Dec-2021
GB-2615061-A Next generation prenatal screening Pending 03-Dec-2021
GB-202013377-D0 3d data structure (redraft) Inactive 26-Aug-2020
GB-202013386-D0 Application of pathogenicity model and training thereof Inactive 26-Aug-2020
To view Congenica’s complete patent history, request access »

Congenica Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Congenica Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds
Downing Infrastructure Minority
IDO Investments Growth/Expansion Minority
Image Frame Investment Corporate Venture Capital Minority
Angel (individual) Minority
Legal & General Group Corporation Minority
You’re viewing 5 of 21 investors. Get the full list »

Congenica FAQs

  • When was Congenica founded?

    Congenica was founded in 2012.

  • Where is Congenica headquartered?

    Congenica is headquartered in Cambridge, United Kingdom.

  • What is the size of Congenica?

    Congenica has 57 total employees.

  • What industry is Congenica in?

    Congenica’s primary industry is Decision/Risk Analysis.

  • Is Congenica a private or public company?

    Congenica is a Private company.

  • What is Congenica’s current revenue?

    The current revenue for Congenica is .

  • How much funding has Congenica raised over time?

    Congenica has raised $89.8M.

  • Who are Congenica’s investors?

    Downing, IDO Investments, Image Frame Investment, , and Legal & General Group are 5 of 21 investors who have invested in Congenica.

  • Who are Congenica’s competitors?

    PierianDx, Superfluid DX, Genalice, Rosalind (Decision/Risk Analysis), and Fabric Genomics are some of the 30 competitors of Congenica.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »